Slagle Financial
GILD icon

Slagle Financial’s Gilead Sciences GILD Stock Holding History

Slagle Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$244K Sell
1,640
-107
-6% -$15K 0.07% 118
2026
Q2 		$221K Sell
1,747
-38
-2% -$5.01K 0.07% 124
2026
Q1 		$249K Sell
1,785
-131
-7% -$18.3K 0.08% 107
2025
Q4 		$235K Sell
1,916
-324
-14% -$39.4K 0.08% 105
2025
Q3 		$249K Sell
2,240
-30
-1% -$3.41K 0.09% 101
2025
Q2 		$252K Sell
2,270
-66
-3% -$7.02K 0.1% 99
2025
Q1 		$262K Sell
2,336
-25,788
-92% -$2.66M 0.12% 88
2024
Q4 		$2.6M Buy
28,124
+1,100
+4% +$99K 1.17% 32
2024
Q3 		$2.27M Buy
27,024
+1,347
+5% +$103K 1.01% 40
2024
Q2 		$1.76M Buy
25,677
+1,055
+4% +$70.4K 0.9% 49
2024
Q1 		$1.8M Sell
24,622
-26,508
-52% -$2.04M 0.98% 44
2023
Q4 		$2.07M Buy
51,130
+25,438
+99% +$1.98M 1.19% 37
2023
Q3 		$1.93M Buy
25,692
+1,227
+5% +$94.4K 1.18% 31
2023
Q2 		$1.89M Buy
+24,465
New +$1.95M 1.17% 35

Other funds holding GILD

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Slagle Financial's GILD Position: Q3 2026 in Review

Slagle Financial reduced its Gilead Sciences (GILD) stake by 6.1% in Q3 2026, selling an estimated $15K and leaving 1,640 shares worth $244K. The position accounts for 0.07% of the portfolio, ranked #118.

Slagle Financial first reported a position in GILD in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.6M in Q4 2024. 1,826 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Slagle Financial held 1,640 shares of Gilead Sciences worth $244K as of Q3 2026.
  • Slagle Financial sold 107 Gilead Sciences shares in Q3 2026, an estimated $15K.
  • Gilead Sciences made up 0.07% of Slagle Financial's portfolio in Q3 2026, its #118 holding.
  • Slagle Financial first reported a position in Gilead Sciences in Q2 2023 and has held it in 14 quarters since.
  • Slagle Financial's Gilead Sciences position peaked at $2.6M in Q4 2024.
  • 1,826 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Slagle Financial's 13F filing for Q3 2026, filed 12 Nov 2026.